“De-risking the commercialisation of Health-Tech innovations” We provide expert advice on the commercialisation of biotech and medtech innovations, beyond the Regulatory Clearances, i.e. Health Economics, Reimbursement, Distribution and most importantly Adoption. Med2Mark thoroughly assesses the commercial value of Health-Tech innovations before significant investments are committed. We are an international boutique Consulting Practice with over twenty years’ experience in the commercialisation of Biotech and Medtech innovations in the USA, Europe, Asia and Australia